PMC:7079862 / 20019-20264 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"705","span":{"begin":41,"end":49},"obj":"Species"},{"id":"707","span":{"begin":55,"end":64},"obj":"Species"},{"id":"708","span":{"begin":137,"end":146},"obj":"Species"},{"id":"710","span":{"begin":88,"end":97},"obj":"Chemical"},{"id":"711","span":{"begin":182,"end":193},"obj":"Chemical"}],"attributes":[{"id":"A705","pred":"tao:has_database_id","subj":"705","obj":"Tax:9606"},{"id":"A707","pred":"tao:has_database_id","subj":"707","obj":"Tax:11520"},{"id":"A708","pred":"tao:has_database_id","subj":"708","obj":"Tax:11520"},{"id":"A710","pred":"tao:has_database_id","subj":"710","obj":"MESH:C000628402"},{"id":"A711","pred":"tao:has_database_id","subj":"711","obj":"MESH:D053139"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Two phase III trials in non-hospitalized patients with influenza found that single-dose baloxavir was superior to placebo in alleviating influenza symptoms, and was superior to both oseltamivir and placebo in reducing viral replication [20, 21]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T146","span":{"begin":55,"end":64},"obj":"Disease"},{"id":"T147","span":{"begin":137,"end":146},"obj":"Disease"}],"attributes":[{"id":"A146","pred":"mondo_id","subj":"T146","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A147","pred":"mondo_id","subj":"T147","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"}],"text":"Two phase III trials in non-hospitalized patients with influenza found that single-dose baloxavir was superior to placebo in alleviating influenza symptoms, and was superior to both oseltamivir and placebo in reducing viral replication [20, 21]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T166","span":{"begin":182,"end":193},"obj":"Chemical"}],"attributes":[{"id":"A166","pred":"chebi_id","subj":"T166","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"}],"text":"Two phase III trials in non-hospitalized patients with influenza found that single-dose baloxavir was superior to placebo in alleviating influenza symptoms, and was superior to both oseltamivir and placebo in reducing viral replication [20, 21]."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T16","span":{"begin":218,"end":235},"obj":"http://purl.obolibrary.org/obo/GO_0019079"},{"id":"T17","span":{"begin":218,"end":235},"obj":"http://purl.obolibrary.org/obo/GO_0019058"}],"text":"Two phase III trials in non-hospitalized patients with influenza found that single-dose baloxavir was superior to placebo in alleviating influenza symptoms, and was superior to both oseltamivir and placebo in reducing viral replication [20, 21]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T158","span":{"begin":0,"end":245},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Two phase III trials in non-hospitalized patients with influenza found that single-dose baloxavir was superior to placebo in alleviating influenza symptoms, and was superior to both oseltamivir and placebo in reducing viral replication [20, 21]."}

{"project":"2_test","denotations":[{"id":"32040667-30724789-47981293","span":{"begin":237,"end":239},"obj":"30724789"},{"id":"T35667","span":{"begin":237,"end":239},"obj":"30724789"}],"text":"Two phase III trials in non-hospitalized patients with influenza found that single-dose baloxavir was superior to placebo in alleviating influenza symptoms, and was superior to both oseltamivir and placebo in reducing viral replication [20, 21]."}